Skip to main content
World Congress on Medical Oncology
Olympic Paris 2024
Test 4
Test 1
Test 2
Test 5
Test 3
Test clone mv
Olympic Paris 2024
Olympic Paris 2024 - VIP - Boss Ticket
Olympic Paris 2024
Finance Code Test
Concrete Institute of Australia’s Biennial National Conference 2025
Concrete Institute of Australia’s Biennial National Conference 2025
Test Goldenowl Conference
Virtual Event 01
Paris Olypmpic Clone 12.09 webinar
7th World Congress of Nanoentomology
NDS NAB Transact testing
JC test 01
Pre-Release 3 Oct
DEX (Digital Employee Experience) conference 2024
test derek
TimeZone Test
TimeZone Test
Talent Events
Event Demo
Olympic Paris 2024 x
original event name for cloning testing
Olympic Paris 2024
Default payment method test
evexus Event - 509
Default payment method test2
Test Worker
Test Worker
charlie test
Arinex 1
NET24 Ho Chi Minh City Workshop 2024
Telefilm 2024 - International Exhibition of Film and Television Technology in Vietnam
Olympic Paris 2024
charlie test 2711
charlie test 2711 cloned
CICM SecurePay testing
The AI Submit 2024
Test webinar 04.12 - - - -
Taylor Swift Clone 04
Taylor Swift Clone 02
Taylor Swift
Taylor Swift Clone
Taylor Swift Clone 01
Import Test
The Trading Summit 2024 (HCM - Vietnam)
Electric Dreams: A Synthwave Extravaganza
Taylor Swift 16
Taylor Swift 12
Taylor Swift 14
Taylor Swift 15
Taylor Swift 17
Taylor Swift 20
Coin Based Hackathon 2024
Rose 01
Import Ticket
Vu Cat Tuong
STEM 1
Kids STEM
CLONE Innovate 2025: A Future Forward Summit
Innovate 2025: A Future Forward Summit
Petals & Sunshine Festival
webinar 05/02
Science
evexus Event - 273
evexus Event - 275
Association webinar 5.2
evexus Event - 274
Aurora Nights 2025 - Webinar
Seoul AI Seminar
Webinar Event - Lily AI - 20/02
evexus Event - 287
Taylor Swift 11
Swifties Only Social Contact
cloned event for Bree QA
evexus Event - 288
evexus Event - 289
Bree QA event
Tim's event
Ralph's event
Tim cloned enable all
Ralph clone event the last one
Hawaii AI Seminar
evexus Event - 293
Tokyo Seminar
Indiana AI Seminar
Registration ticket 2025
TechNova Summit
Event - 28 - 03 - 2025
TechNova Summit [2]
TechNova Summit [3]
Tech v1
Event 28/03/2025
Job Affairs
Fan Job
Webinar Event - Lily AI - 04/03
Event Registration
Association webinar 20.2
Fan's stock query
Registration
Aurora Nights 2025
Ralph test email
Taylor Swift 13
The Core 2025
Rose
The Thirdweb submit
Stress Test Conference 2026
Alan'event
World Congress of Medical Oncology
The AI Seoul Submit 2026
The Core 2026
Times are shown in your local time zone GMT
Review of incidental papillary thyroid microcarcinoma recurrence rates and associated risk factors in Western Australia
Verbal Presentation

Verbal Presentation

3:09 pm

01 May 2026

Meeting Room M2

RESEARCH

Talk Description

Institution: Royal Perth Hospital - WA, Australia

Purpose: Papillary thyroid microcarcinoma (PTMC) is an increasingly common diagnosis and associated with an overall excellent prognosis. As a result, there have been calls for de-escalation of PTMC postoperative surveillance. It is also recognised, however, that some patients with PTMC develop locoregional and metastatic disease or recurrence following surgical intervention, suggesting PTMC may represent a more diverse cohort of patients requiring different follow up strategies. This study aimed to assess recurrence rates in a Western Australian cohort of patients with incidental PTMC and identify potential risk factors for recurrence to help guide local practice. Methodology: A retrospective analysis was conducted of all patients with an incidental histopathological diagnosis of PTMC after undergoing thyroid surgery for a benign indication at public hospitals in Western Australia over a 10-year period (2013-2023). Data collected included potential risk factors for recurrence (age, sex, indication for operation, lymphovascular invasion, lymph node metastasis, tumour size, multifocality, thyroiditis, tumour location, extrathyroidal extension, tall cell variant, BRAF mutation) as well as outcome variables (locoregional recurrence, distant recurrence, survival). Results: Data were collected from 182 patients. Only 1 patient had locoregional recurrence of PTMC 14 months after the index operation. Potential risk factors for recurrence present in this patient included male sex, >5mm tumour, multifocality, positive BRAF mutation and lymph node metastasis identified at the index operation. However, all other patients with these potential risk factors did not develop recurrence. Conclusion: Findings from this study confirm that incidental PTMC has an excellent prognosis in the Western Australian population with very low rates of recurrence despite the presence of potential risk factors. This suggests that incidental PTMC does not require routine postoperative surveillance.
Speakers
Contributors
Authors

Dr Alexandra Miller - , Dr Munya Nyandoro - , Dr Sze Ling Wong -

Other Suggested Talks
Privacy Statement Header

By confirming your acceptance below, you agree to our Privacy Policy